SK17594A3 - Pyrazine derivatives, their preparation and their use - Google Patents
Pyrazine derivatives, their preparation and their use Download PDFInfo
- Publication number
- SK17594A3 SK17594A3 SK175-94A SK17594A SK17594A3 SK 17594 A3 SK17594 A3 SK 17594A3 SK 17594 A SK17594 A SK 17594A SK 17594 A3 SK17594 A3 SK 17594A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- group
- formula
- substituted
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4127026A DE4127026A1 (de) | 1991-08-16 | 1991-08-16 | Neue pyrazinderivate, ihre herstellung und verwendung |
DE19914130461 DE4130461A1 (de) | 1991-09-13 | 1991-09-13 | Neue pyrazinderivate, ihre herstellung und verwendung |
PCT/EP1992/001738 WO1993004048A1 (de) | 1991-08-16 | 1992-07-31 | Neue pyrazinderivative, ihre herstellung und verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
SK17594A3 true SK17594A3 (en) | 1994-12-07 |
Family
ID=25906394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK175-94A SK17594A3 (en) | 1991-08-16 | 1992-07-31 | Pyrazine derivatives, their preparation and their use |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0598770B1 (sl) |
JP (1) | JPH06509798A (sl) |
AT (1) | ATE159250T1 (sl) |
AU (1) | AU669122B2 (sl) |
CA (1) | CA2115755A1 (sl) |
CZ (1) | CZ280760B6 (sl) |
DE (1) | DE59208974D1 (sl) |
DK (1) | DK0598770T3 (sl) |
ES (1) | ES2108129T3 (sl) |
FI (1) | FI940696A0 (sl) |
GR (1) | GR3025742T3 (sl) |
HK (1) | HK1003137A1 (sl) |
HU (1) | HUT67661A (sl) |
IE (1) | IE922592A1 (sl) |
IL (1) | IL102814A0 (sl) |
MX (1) | MX9204637A (sl) |
NO (1) | NO301542B1 (sl) |
NZ (1) | NZ243959A (sl) |
RU (1) | RU2124008C1 (sl) |
SG (1) | SG46307A1 (sl) |
SK (1) | SK17594A3 (sl) |
TW (1) | TW213903B (sl) |
WO (1) | WO1993004048A1 (sl) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6645969B1 (en) | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4325822A1 (de) * | 1993-07-31 | 1995-02-02 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US5852046A (en) * | 1993-08-03 | 1998-12-22 | Hoechst Aktiengesellschaft | Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them |
DE4337609A1 (de) * | 1993-11-04 | 1995-05-11 | Boehringer Ingelheim Kg | Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln |
DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US5760230A (en) * | 1996-10-11 | 1998-06-02 | Bayer Aktiengesellschaft | 4, 4'-bridged bis-2, 4-diaminoquinazolines |
US6420354B1 (en) * | 1998-06-08 | 2002-07-16 | Advanced Medicine, Inc. | Sodium channel drugs and uses |
EP1182194A4 (en) | 1999-06-03 | 2004-02-11 | Takeda Chemical Industries Ltd | PERNASAL COMPOSITIONS |
US6479498B1 (en) | 1999-06-04 | 2002-11-12 | Theravance, Inc. | Sodium channel drugs and uses |
US6156758A (en) * | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
US7501417B2 (en) * | 2002-03-13 | 2009-03-10 | Janssen Pharmaceutica, N.V. | Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
CA2536975A1 (en) | 2003-08-28 | 2005-03-17 | Nitromed, Inc. | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
WO2006091716A2 (en) | 2005-02-24 | 2006-08-31 | Nitromed, Inc. | Nitric oxide enhancing diuretic compounds, compositions and methods of use |
DE102008061247A1 (de) | 2008-12-10 | 2010-06-24 | Christian-Albrechts-Universität Zu Kiel | Inhibitoren der Dimethylarginin Dimethylaminohydrolase |
US8987288B2 (en) * | 2010-09-10 | 2015-03-24 | Hangzhou Bensheng Pharmaceutical Co., Ltd. | Heterocyclic aminoberbamine derivatives, the preparation process and use thereof |
CN110041291B (zh) * | 2018-01-15 | 2021-02-26 | 北京采瑞医药科技研究院有限公司 | 一种玛咖酰胺衍生物及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL299931A (sl) * | 1962-10-30 | |||
US3527758A (en) * | 1967-04-13 | 1970-09-08 | Merck & Co Inc | Process for the preparation of pyrazinoylguanidines from a pyrazinoic azide and a guanidine |
US3539569A (en) * | 1968-08-21 | 1970-11-10 | Merck & Co Inc | Preparation of pyrazinoylguanidines from pyrazinoylureas |
NL7803906A (nl) * | 1978-04-12 | 1979-10-16 | Noordvos Schroeven Bv | Werkwijze, inrichting en propeller voor het verdelen van een gasvormig, poedervormig of vloeibaar materiaal in een vloeistof. |
-
1992
- 1992-07-28 TW TW081105973A patent/TW213903B/zh active
- 1992-07-31 EP EP92916697A patent/EP0598770B1/de not_active Expired - Lifetime
- 1992-07-31 SK SK175-94A patent/SK17594A3/sk unknown
- 1992-07-31 CZ CZ94337A patent/CZ280760B6/cs unknown
- 1992-07-31 ES ES92916697T patent/ES2108129T3/es not_active Expired - Lifetime
- 1992-07-31 SG SG1996002613A patent/SG46307A1/en unknown
- 1992-07-31 RU RU94015265A patent/RU2124008C1/ru active
- 1992-07-31 CA CA002115755A patent/CA2115755A1/en not_active Abandoned
- 1992-07-31 JP JP5504057A patent/JPH06509798A/ja active Pending
- 1992-07-31 WO PCT/EP1992/001738 patent/WO1993004048A1/de active IP Right Grant
- 1992-07-31 AT AT92916697T patent/ATE159250T1/de not_active IP Right Cessation
- 1992-07-31 HU HU9400430A patent/HUT67661A/hu unknown
- 1992-07-31 DE DE59208974T patent/DE59208974D1/de not_active Expired - Fee Related
- 1992-07-31 DK DK92916697.3T patent/DK0598770T3/da active
- 1992-07-31 AU AU23870/92A patent/AU669122B2/en not_active Ceased
- 1992-08-11 MX MX9204637A patent/MX9204637A/es not_active IP Right Cessation
- 1992-08-14 NZ NZ243959A patent/NZ243959A/en unknown
- 1992-08-14 IL IL102814A patent/IL102814A0/xx unknown
- 1992-08-17 IE IE259292A patent/IE922592A1/en not_active IP Right Cessation
-
1994
- 1994-02-15 NO NO940523A patent/NO301542B1/no unknown
- 1994-02-15 FI FI940696A patent/FI940696A0/fi unknown
-
1997
- 1997-12-23 GR GR970403392T patent/GR3025742T3/el unknown
-
1998
- 1998-03-17 HK HK98102228A patent/HK1003137A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO301542B1 (no) | 1997-11-10 |
SG46307A1 (en) | 1998-02-20 |
MX9204637A (es) | 1993-02-01 |
EP0598770B1 (de) | 1997-10-15 |
ES2108129T3 (es) | 1997-12-16 |
HK1003137A1 (en) | 1998-10-09 |
FI940696A (fi) | 1994-02-15 |
TW213903B (sl) | 1993-10-01 |
ATE159250T1 (de) | 1997-11-15 |
WO1993004048A1 (de) | 1993-03-04 |
CZ280760B6 (cs) | 1996-04-17 |
FI940696A0 (fi) | 1994-02-15 |
AU2387092A (en) | 1993-03-16 |
RU2124008C1 (ru) | 1998-12-27 |
HUT67661A (en) | 1995-04-28 |
DK0598770T3 (da) | 1997-12-15 |
JPH06509798A (ja) | 1994-11-02 |
EP0598770A1 (de) | 1994-06-01 |
NO940523D0 (no) | 1994-02-15 |
NZ243959A (en) | 1995-07-26 |
NO940523L (no) | 1994-02-15 |
GR3025742T3 (en) | 1998-03-31 |
CA2115755A1 (en) | 1993-03-04 |
IE922592A1 (en) | 1993-02-24 |
RU94015265A (ru) | 1997-02-20 |
IL102814A0 (en) | 1993-01-31 |
HU9400430D0 (en) | 1994-05-30 |
DE59208974D1 (de) | 1997-11-20 |
AU669122B2 (en) | 1996-05-30 |
CZ33794A3 (en) | 1994-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK17594A3 (en) | Pyrazine derivatives, their preparation and their use | |
DK2346837T3 (en) | Methods for preparing quinazolinone derivatives | |
SK282080B6 (sk) | Substituované salicylové kyseliny a ich použitie | |
KR20060009900A (ko) | 피페리디닐- 및 피페라지닐-알킬 카르바메이트 유도체,그의 제조 방법 및 그의 치료 용도 | |
FI63934C (fi) | Foerfarande foer framstaellning av 6,7-dimetoxi-4-(4-substituerad piperidino)kinazoliner anvaendbara foer behandling av brstande hjaertfunktion | |
JP6704422B2 (ja) | キナゾリン誘導体の塩およびその製造方法 | |
KR20010072439A (ko) | 치환된 4-아미노-2-아릴-피리미딘, 이의 제조방법 및용도, 및 이를 함유하는 약제학적 제제 | |
WO2014078309A1 (en) | Cannabinoid receptor mediating compounds | |
US20040248918A1 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
EP3303325A1 (en) | Cannabinoid receptor mediating compounds | |
US5210086A (en) | 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapy | |
JP4623354B2 (ja) | 新規ピリミジン誘導体及び新規ピリジン誘導体 | |
US20040132786A1 (en) | Differential tumor cytotoxicity compounds and compositions | |
US20230067045A1 (en) | Thiophene[2,3-d]pyrimidine derivative dk6-1 and its preparation method and application | |
US5229392A (en) | 2-aminopyrimidine-4-carboxamide derivatives, their preparaton and their application in therapy | |
EP0690051B1 (en) | Diazacycloalkanealkylsulfonamide derivative | |
CN110563656A (zh) | 嘧啶类小分子化合物及在制备抗分枝杆菌药物中的用途 | |
DE4127026A1 (de) | Neue pyrazinderivate, ihre herstellung und verwendung | |
US5330985A (en) | 2-amino-N-[[4-(aminocarbonyl)pyrimidin-2-yl]amino]-alkyl]pyrimidine-4-carboxamide derivatives, their preparation and pharmaceutical compositions containing them | |
US2465568A (en) | Pyrimidine compounds | |
US5420130A (en) | 2-aminopyrazine-5-carboxamide derivatives, their preparation and their application in therapeutics | |
JP2846070B2 (ja) | カルボキシイミダミド誘導体 | |
JP2010501007A (ja) | チオ尿素化合物 | |
DE4130461A1 (de) | Neue pyrazinderivate, ihre herstellung und verwendung | |
CS218022B1 (cs) | Deriváty 2-piperazino-4-amino-6,7-dimethoxychinazolina a způsoby jejich přípravy |